Jobs fight needs your supporı
Socialist Organiser1992 1992-01-23Read it in the scan (PDF), scan page 15 →
Read from the scan by machine and not corrected: expect misread words, and now and then a caption or a line from a neighbouring story. For anything you quote, read the scan.
Scan page 15
Telecom: national action needed Over the last few years, too many groups of workers have been left to fight alone or sold down the river by their union officials.
Others have lacked the confidence to go into battle in what they have seen as very unfavourable cirelsewhere to fight back. • Invite a striker to speak at your trade union or Labour Party meeting.
• Make a donation to the strike fund.
• Try and get a levy for the GEC strikers going at your workplace.
threatening de-recognition if the over ime an aie wOrk-1O-uIC Kratst AlrWas fleet of jumbo afe is to he mover Topenshaw is the fire he strike of GEC since the Maastricht European Summit in which workers are pushing their dispute at an international level.
From the first registration of the dispute, the unions have been in contact with the CGT - the trade unions federation in France (where GEC Alsthom is based), asking the CGT for solidarity.
They hope to gain access to the company's plans for the Openshaw plant through the Tare being targeted by elecoms workers over 60 British Telecom (BT) for compulsory "retirement" - that's sacking to you and me.
The National Communications Union (NCU) is divided as to whether to fight on this issue or not.
Industrial action to stop the CPSA stop press The DHSS Section Executive of the Civil and Public Services Association (CPSA) has just voted to negotiate a redundancy package with the Government's Department of Social Security (DSS).
Though restricted, for now, to workers in the settlement centres, the decision represents a dangerous precedent.
*With management on the offensive over pay, national bargaining, badges and uniforms, this is a decision we will come to regret" , was how Section Executive member Mari Serwotka responded. The Section Executive, which normally has a left-wing majority, took the decision when Militant supporters broke with the Broad Left majority and voted with the right wing. A fight on staff ing was blocked by the right wing Section Chair.
Full report next week. see company documents. If ti company refuses, the unions can take them to the French courts.
The MSF at Openshaw are also demanding the workers? rights under the Treaty of Rome (article 1186) to intern: tional meetings with management in France.
Ultimately, they want to build an international GEC Combine Committee across Europe.
Openshaw MSF branch chai Rick Hesketh, told Socialist Organiser: "the one thing the multi-national companies fear most is multi-national trade union action. That is going to help us win"
sackings is being taken by Westminster Branch and other branches are ballotting. Meanwhile, the possibilities of compromise deals at a national level have faded in the face of BT's intransigence.
The way forward is surely to defend the over-60s and their right to work until the state retirement age; anything less is not justice.
There is no doubting the financial hardship that BT's policy is causing.
Nevertheless, the significance of the over-60s issue is not just one of BT badly treating one group of workers but that this is just the beginning of a massive attack on the jobs and working conditions of all NCU members.
The gap between workers leaving on voluntary redundancy terms and planned staff reductions is growing wider, with the only solutions on offer being a change in BT policies on staffing (unlikely) or compulsory redundancies in the near future (very likely).
We must face the facts and take a stand now to defend the over-60s - knowing we will be next. The way forward is for more branches to take action and to give BT the message that we are not prepared to sacrifice the over-60s.
The NCU Executive need to be told this as well: at the national meeting of branch delegates arranged for later this month, branches need to press for a national campaign on this issue.
CONUIVIN
he frenetic pace of genetic research since recombinant DNA techniques were introduced seems to be bearing fruit in the form of an effective treatment for cystic fibrosis.
The tragedy of many fatal genetic diseases has challenged researchers to find ways of replacing faulty genes. Hitherto, medical science has only been able to offer palliatives - donated blood COLLIS factors for people with haemophilia; antibiotics and physiotherapy for people with cystic fibrosis; etc. The result has often been a prolonged but still short and sometimes paintul life.
Gene therapy has a short and slightly checkered history. Unauthorised experiments human sufferers of thalassaemia debilitating blood disorder) were carried out in 1984 by US researcher Martin Cline.
For his irresponsibility, Cline lost nis researcher's licence, though the "guinea pigs" appear to have neither suffered nor benefitted from his attempts to insert healthy hemoglobin genes into bone marrow cells.
More recently, successful gene therapy has been carried out on a young victim of Severe Combined Deficiency (SCID). People with SCID are nable to make a protein called adenine deaminase (ADA) due to a defect in the ADA gene. The result is a crippled immune system and victims usually Che infancy from overhelming infection.
One boy in Texas spent his short life in a plastic bubble designed to keep out bacteria and viruses.
lowever, a 4-year old gi ith SCID has been able t Leat an essentially normal life, apart from transfusions of white blood cells every couple of months or so. The cells are her own, previously removed and treated to insert normal copies of the ADA gene. since winte cels Have d limited life span, regular replacements are necessary.
A permanent cure might be effected by inserting the normal genes into the stem cells, gressive destruction of the lung tissues.
Most sufferers die before the age of 30.
Interestingly, a single copy of the faulty gene, the most common genetic defect in European populations, seems to protect against death from gut infections.
CF research has really taken off since the gene for CF was discovered in 1989 by US and Canadian scientists, with a team at St. Mary's Hospital being pipped at the post. Now, a team at the Heart, Lung and Blood Institute, Bethesda, Maryland, has found a way of introducing the healthy gene into the cells of lung membranes of experimental rats. Once in these cells, the genes are fully operational.
The method of introduction is quite ingenious. Lung cells cannot be taken out, modified and put back, unlike white blood cells. So the researchers use an adenovirus which infects lung cells and causes symptoms of common cold.
First, they "disable" the virus, so that it is no longer disease-causing. Then they insert copies of the healthy gene. Finally, they introduce it into the lungs by means of a nasal spray. The virus enters the lung membrane cells, releasing the genes but causing no further effects. The genes then function normally but, over a period of weeks, the cells are naturally lost, necessitating repeat treatments.
Safety aspects will need investigating, but treatment for humans may be possible in just one year. This is surely an answer to scaremongering talk about genetic engineering (as well as to critics of any research using animals).
----- pull-quotes -----
"Gene therapy h short and slightly checkere history"